HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

SPL-2999

inhibits both virus entry and late stages of herpes simplex virus

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Macromolecular Substances: 97
- Polymers: 13051
  - SPL-2999: 1
Biomedical and Dental Materials
- Polymers: 13051
  - SPL-2999: 1
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - SPL-2999: 1

Experts

1.	Cheung, Dorothy: 1 article (08/2002)
2.	Gadawski, Izabelle: 1 article (08/2002)
3.	Gong, Yunhao: 1 article (08/2002)
4.	Holan, George: 1 article (08/2002)
5.	Leung, Daniel: 1 article (08/2002)
6.	Matthews, Barry: 1 article (08/2002)
7.	Raff, John: 1 article (08/2002)
8.	Sacks, Stephen: 1 article (08/2002)
9.	Tam, Teresa: 1 article (08/2002)

Related Diseases

1.	Infections 08/01/2002 - "When Vero cells were infected with HSV at moi (multiplicity of infection) of 0.01 pfu/cell, the infected cells could be completely protected from viral cytopathic effect (CPE) by SPL-2999 with EC(90)s (effective concentration that protects 90% of cells from virus lysis) of 15 microg/ml for HSV-1 and 10 microg/ml for HSV-2. "